The Effects of Acute Administration of Propranolol and Practolol on the Uptake, Content, Release, and Turnover of Noradrenaline in the Rat Heart in Vivo

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1974 Jan 1

PMID 4275629

Citations 5

Authors

B Lemmer

R Saller

Affiliations

Soon will be listed here.

Citing Articles

Antagonism by chlorisondamine and propranolol, but not by atenolol, of the circadian phase-dependent phentolamine-induced changes in the cardiac noradrenaline turnover in the rat.

Lemmer B, Charrier A Naunyn Schmiedebergs Arch Pharmacol. 1980; 313(3):205-12.

PMID: 7432552 DOI: 10.1007/BF00505735.

Influence of beta-adrenoceptor blocking agents on the turnover rate of cardiac and splenic noradrenaline in rats.

Alexandre J, Chevillard C Br J Pharmacol. 1980; 69(1):35-40.

PMID: 6103727 PMC: 2044186. DOI: 10.1111/j.1476-5381.1980.tb10880.x.

Physical activity decreases the number of beta-adrenergic receptors on human lymphocytes.

Krawietz W, Klein E, Unterberg C, Ackenheil M Klin Wochenschr. 1985; 63(2):73-8.

PMID: 2984455 DOI: 10.1007/BF01733071.

Correlation of platelet taurine levels with thyroid function.

Baskin S, Klekotka S, KENDRICK Z, BARTUSKA D J Endocrinol Invest. 1979; 2(3):245-9.

PMID: 528776 DOI: 10.1007/BF03350410.

Concentration of catecholamines in human cardiac muscle.

Petch M, NAYLER W Br Heart J. 1979; 41(3):340-4.

PMID: 426982 PMC: 482037. DOI: 10.1136/hrt.41.3.340.

References

Foo J, Jowett A, Stafford A . The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart. Br J Pharmacol. 1968; 34(1):141-7. PMC: 1703465. DOI: 10.1111/j.1476-5381.1968.tb07957.x. View

Westfall T . Accumulation of norepinephrine in rat tissue following treatment with three beta-adrenergic antagonists. Arch Int Pharmacodyn Ther. 1967; 167(1):69-79. View

Dunlop D, Shanks R . Selective blockade of adrenoceptive beta receptors in the heart. Br J Pharmacol Chemother. 1968; 32(1):201-18. PMC: 1570292. DOI: 10.1111/j.1476-5381.1968.tb00444.x. View

Iversen L, Jarrott B, Simmonds M . Differences in the uptake, storage and metabolism of (+)- and (-)-noradrenaline. Br J Pharmacol. 1971; 43(4):845-55. PMC: 1665715. DOI: 10.1111/j.1476-5381.1971.tb07221.x. View

Fitzgerald J . Perspectives in adrenergic beta-receptor blockade. Clin Pharmacol Ther. 1969; 10(3):292-306. DOI: 10.1002/cpt1969103292. View

Iversen L . The inhibition of noradrenaline uptake by drugs. Adv Drug Res. 1965; 2:1-46. View

Romagnoli A . Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents. J Pharm Pharmacol. 1970; 22(3):235-7. DOI: 10.1111/j.2042-7158.1970.tb08507.x. View

Wiethold G, Hellenbrecht D, Lemmer B, Palm D . Membrane effects of beta-adrenergic blocking agents: investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities. Biochem Pharmacol. 1973; 22(12):1437-49. DOI: 10.1016/0006-2952(73)90322-5. View

Chang C . A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES. Int J Neuropharmacol. 1964; 3:643-9. DOI: 10.1016/0028-3908(64)90089-9. View

10.

LINDMAR R, Muscholl E . [THE EFFECT OF DRUGS ON THE ELIMINATION OF NORADRENALIN FROM PERFUSION FLUID AND NORADRENALIN UPTAKE IN THE ISOLATED HEART]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964; 247:469-92. DOI: 10.1007/BF00329896. View

11.

Dollery C, Paterson J, Conolly M . Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther. 1969; 10(6):765-99. View

12.

Bainbridge J, Greenwood D . Tranquillizing effects of propranolol demonstrated in rats. Neuropharmacology. 1971; 10(4):453-8. DOI: 10.1016/0028-3908(71)90073-6. View

13.

Chang C, Wang W . Antagonism by propranolol of the inhibitory effect of phenoxybenzamine on noradrenaline uptake in vivo. J Pharm Pharmacol. 1971; 23(12):911-7. DOI: 10.1111/j.2042-7158.1971.tb09892.x. View

14.

Farrant J, Harvey J, PENNEFATHER J . THE INFLUENCE OF PHENOXYBENZAMINE ON THE STORAGE OF NORADRENALINE IN RAT AND CAT TISSUES. Br J Pharmacol Chemother. 1964; 22:104-12. PMC: 1703909. DOI: 10.1111/j.1476-5381.1964.tb01547.x. View

15.

Baird J, Linnell J . The assessment of -adrenoceptor blocking potency and cardioselectivity in vitro and in vivo. J Pharm Pharmacol. 1972; 24(11):880-5. DOI: 10.1111/j.2042-7158.1972.tb08907.x. View

16.

Hellenbrecht D, Lemmer B, Wiethold G, Grobecker H . Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents. Naunyn Schmiedebergs Arch Pharmacol. 1973; 277(2):211-26. DOI: 10.1007/BF00501161. View

17.

ABRAMS W, Solomon H . The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine. Clin Pharmacol Ther. 1969; 10(5):702-9. DOI: 10.1002/cpt1969105702. View

18.

Brick I, Hutchison K, McDevitt D, Roddie I, Shanks R . Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. Br J Pharmacol. 1968; 34(1):127-40. PMC: 1703393. DOI: 10.1111/j.1476-5381.1968.tb07956.x. View

19.

Klinge E . Effect of beta-adrenergic blocking compounds on tissue catecholamine levels. Eur J Pharmacol. 1971; 14(2):124-9. DOI: 10.1016/0014-2999(71)90205-6. View

20.

LESZKOVSZKY G, TARDOS L . Some effects of propranolol on the central nervous system. J Pharm Pharmacol. 1965; 17(8):518-9. DOI: 10.1111/j.2042-7158.1965.tb07715.x. View